Rhythm Pharmaceuticals is a biopharmaceutical company focused on rare neuroendocrine diseases. Their lead product candidate, IMCIVREE, targets various obesity-related disorders. The company has licensing agreements and collaborations to advance their research in these areas.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing